Invasive Aspergillosis in the Setting of Cardiac Transplantation

Clinical Infectious Diseases

Volumn 37, Issue SUPPL. 3, 2003, Pages

  Montoya, J G ^a,c   Chaparro, S V ^a   Celis, D ^a,d   Cortes J A ^a,d   Leung, A N ^a   Robbins, R C ^a   Stevens, D A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SANTA CLARA VALLEY MEDICAL CENTER   (United States)

^c PALO ALTO MEDICAL FOUNDATION RESEARCH INSTITUTE   (United States)

^d UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AZATHIOPRINE; CYCLOSPORIN; GANCICLOVIR; ITRACONAZOLE; LEUKOCYTE ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COUGHING; FEMALE; FEVER; FUNGUS CULTURE; GRAFT REJECTION; HEART DISEASE; HEART TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ASPERGILLOSIS; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; NONHUMAN; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; THORAX RADIOGRAPHY; ASPERGILLUS FUMIGATUS; CHEMOPROPHYLAXIS; COMPARATIVE STUDY; IMMUNE DEFICIENCY; MORTALITY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; RISK FACTOR;

ADULT; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CHEMOPREVENTION; FEMALE; HEART TRANSPLANTATION; HUMANS; IMMUNOCOMPROMISED HOST; MALE; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 0141887303     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/376527     Document Type: Article

References (38)

1. Gurwith MJ, Stinson EB, Remington JS. Aspergillus infection complicating cardiac transplantation. Report of five cases. Arch Intern Med 1971; 128:541-5.
2. Hibberd PL, Rubin RH. Clinical aspects of fungal infection in organ transplant recipients. Clin Infect Dis 1994; 19(Suppl 1):S33-40.
3. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34:909-17.
4. Denning DW. Invasive aspergillosis. Clin Infect Dis 1998; 26:781-803; quiz, 804-5.
5. Britt RH, Enzmann DR, Remington JS. Intracranial infection in cardiac transplant recipients. Ann Neurol 1981; 9:107-19.
6. Grossi P, Farina C, Fiocchi R, Dalla Gasperina D. Prevalence and outcome of invasive fungal infections in 1,963 thoracic organ transplant recipients: a multicenter retrospective study. Italian Study Group of Fungal Infections in Thoracic Organ Transplant Recipients. Transplantation 2000; 70:112-6.
7. Hofflin JM, Potasman I, Baldwin JC, Oyer PE, Stinson EB, Remington JS. Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med 1987; 106:209-16.
8. Montoya JG, Giraldo LF, Efron B, et al. Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis 2001; 33:629-40.
9. Patterson TF, Kirkpatrick WR, White M, et al. Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group. Medicine (Baltimore) 2000; 79:250-60.
10. Denning DW. Diagnosis and management of invasive aspergillosis. Curr Clin Top Infect Dis 1996; 16:277-99.
11. Hunt SA. Current status of cardiac transplantation. JAMA 1998; 280: 1692-8.
12. Baumgartner WA, Reitz BA, Bieber CP, Oyer PE, Shumway NE, Stinson EB. Current expectations in cardiac transplantation. J Thorac Cardiovasc Surg 1978; 75:525-30.
13. Baumgartner WA, Reitz BA, Oyer PE, Stinson EB, Shumway NE. Cardiac homotransplantation. Curr Probl Surg 1979; 16:1-61.
14. Reichenspurner H, Gamberg P, Nitschke M, et al. Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. Transplant Proc 1997; 29:627-8.
15. Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis 2002; 34:7-14.
16. Robbins RC, Barlow CW, Oyer PE, et al. Thirty years of cardiac transplantation at Stanford University. J Thorac Cardiovasc Surg 1999; 117: 939-51.
17. Hauggaard A, Ellis M, Ekelund L. Early chest radiography and CT in the diagnosis, management, and outcome of invasive pulmonary aspergillosis. Acta Radiol 2002; 43:292-8.
18. Cisneros JM, Munoz P, Torre-Cisneros J, et al. Pneumonia after heart transplantation: a multi-institutional study. Spanish Transplantation Infection Study Group. Clin Infect Dis 1998; 27:324-31.
19. Yeldandi V, Laghi F, McCabe MA, et al. Aspergillus and lung transplantation. J Heart Lung Transplant 1995; 14:883-90.
20. Grossi P, De Maria R, Caroli A, Zaina MS, Minoli L. Infections in heart transplant recipients: the experience of the Italian heart transplantation program. Italian Study Group on Infections in Heart Transplantation. J Heart Lung Transplant 1992; 11:847-66.
21. Wald A, Leisenring W, van Burik JA, Bowden RA. Epidemiology of Aspergillus infections in a large cohort of patients undergoing bone marrow transplantation. J Infect Dis 1997; 175:1459-66.
22. Cohen MS, Isturiz RE, Malech HL, et al. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi. Am J Med 1981; 71:59-66.
23. Gustafson TL, Schaffner W, Lavely GB, Stratton CW, Johnson HK, Hutcheson RH Jr. Invasive aspergillosis in renal transplant recipients: correlation with corticosteroid therapy. J Infect Dis 1983; 148:230-8.
24. Gerson SL, Talbot GH, Hurwitz S, Strom BL, Lusk EJ, Cassileth PA. Prolonged granulocytopenia: the major risk factor for invasive pulmonary aspergillosis in patients with acute leukemia. Ann Intern Med 1984; 100:345-51.
25. Brown MJ, Worthy SA, Flint JD, Muller NL. Invasive aspergillosis in the immunocompromised host: utility of computed tomography and bronchoalveolar lavage. Clin Radiol 1998; 53:255-7.
26. Haramati LB, Schulman LL, Austin JH. Lung nodules and masses after cardiac transplantation. Radiology 1993; 188:491-7.
27. Leung AN, Gosselin MV, Napper CH, et al. Pulmonary infections after bone marrow transplantation: clinical and radiographic findings. Radiology 1999; 210:699-710.
28. Kuhlman JE, Fishman EK, Siegelman SS. Invasive pulmonary aspergillosis in acute leukemia: characteristic findings on CT, the CT halo sign, and the role of CT in early diagnosis. Radiology 1985; 157:611-4.
29. Kuhlman JE, Fishman EK, Burch PA, Karp JE, Zerhouni EA, Siegelman SS. CT of invasive pulmonary aspergillosis. AJR Am J Roentgenol 1988; 150:1015-20.
30. Cenci E, Perito S, Enssle KH, et al. Th1 and Th2 cytokines in mice with invasive aspergillosis. Infect Immun 1997; 65:564-70.
31. Chauhan B, Santiago L, Hutcheson PS, et al. Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2000; 106:723-9.
32. Chauhan B, Santiago L, Kirschmann DA, et al. The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J Immunol 1997; 159:4072-6.
33. Chauhan B, Knutsen A, Hutcheson PS, Slavin RG, Bellone CJ. T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J Clin Invest 1996; 97:2324-31.
34. Husni RN, Gordon SM, Longworth DL, et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998; 26:753-5.
35. Schwartz S, Behre G, Heinemann V, et al. Aerosolized amphotericin B inhalations as prophylaxis of invasive aspergjllus infections during prolonged neutropenia: results of a prospective randomized multicenter trial. Blood 1999; 93:3654-61.
36. Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 2002; 347:408-15.
37. Maertens J, Raad I, Sable C, et al. Multicenter, noncomparative study to evaluate safety and efficacy of caspofungin (CAS) in adults with invasive aspergillosis (IA) refractory or intolerant to amphotericin B (AMB), AMB lipid formulations (lipid AMB), or azoles [abstract J-1103]. In: Program and abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 2000.
38. Deresinski SC, Stevens DA. Caspofungin. Clin Infect Dis 2003; 36: 1445-57